The Clinical and Research Support Core will be the focal point of much of the activity in the Alzheimer's Disease Research Center (ADRC). This Core will be responsible for the recruitment and characterization of cognitively impaired subjects and normal control individuals in both Rochester, MN and Jacksonville, FL. In Rochester, patients will be derived from community and regional resources and control subjects will be recruited from the community. In Jacksonville, African American and indigent cognitively impaired subjects and a normal control cohort of American-American subjects will be established as well. Most of the these activities will be a continuation of current practices in the Mayo Alzheimer's Disease Center. The cognitively impaired and normal control subjects at both sites will be evaluated in an identical fashion and all of the data will be entered into a common database. The subjects will be screened for a variety of research projects including epidemiology, natural history, neuropsychology, neuroimaging, investigational drug trials, predictor studies, neuropathology and genetic studies. The individuals recruited will be used to address the scientific themes of the ADRC: neuroepidemiology of aging and dementia, boundary between normal aging and very early cognitive impairment, and predictors of cognitive deterioration. A mechanism is in place for longitudinal follow-up of all of these subjects. The Clinical and Research Support Core will also continue the development and maintenance of a centralized database. The database has been created for clinical, neuropsychological, neuroimaging and neuropathology data from Rochester and Jacksonville and this database will be expanded. Quality control measures are in place for the maintenance for the database and programming capabilities are available for modifications. The Core will also serve the ADRC consultation expertise in epidemiology and biostatistics.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG016574-01S4
Application #
6396654
Study Section
Project Start
1999-09-30
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Ferman, Tanis J; Aoki, Naoya; Crook, Julia E et al. (2018) The limbic and neocortical contribution of ?-synuclein, tau, and amyloid ? to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330-339
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Vemuri, Prashanthi; Lesnick, Timothy G; Przybelski, Scott A et al. (2018) Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol 84:705-716
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Lowe, Val J; Lundt, Emily S; Senjem, Matthew L et al. (2018) White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-? Deposition. J Nucl Med 59:1583-1589

Showing the most recent 10 out of 1014 publications